|
Journal of Zhejiang University SCIENCE B
ISSN 1673-1581(Print), 1862-1783(Online), Monthly
2014 Vol.15 No.5 P.412-428
Epigenetic regulation by polycomb group complexes: focus on roles of CBX proteins
Abstract: Polycomb group (PcG) complexes are epigenetic regulatory complexes that conduct transcriptional repression of target genes via modifying the chromatin. The two best characterized forms of PcG complexes, polycomb repressive complexes 1 and 2 (PRC1 and PRC2), are required for maintaining the stemness of embryonic stem cells and many types of adult stem cells. The spectra of target genes for PRCs are dynamically changing with cell differentiation, which is essential for proper decisions on cell fate during developmental processes. Chromobox (CBX) family proteins are canonical components in PRC1, responsible for targeting PRC1 to the chromatin. Recent studies highlight the function specifications among CBX family members in undifferentiated and differentiated stem cells, which reveal the interplay between compositional diversity and functional specificity of PRC1. In this review, we summarize the current knowledge about targeting and functional mechanisms of PRCs, emphasizing the recent breakthroughs related to CBX proteins under a number of physiological and pathological conditions.
Key words: Polycomb, Polycomb repressive complex 1 (PRC1), Chromobox (CBX) protein, Epigenetic regulation, Cancer
创新要点:现已有大量有关PcG在表观遗传水平对其靶基因进行修饰转录机制的综述报道,且以PRC1和PRC2为整体来介绍表观遗传调控机制的文章也屡见不鲜。然而,关于PRC1核心成员CBX蛋白在哺乳动中的同源蛋白CBX2、CBX4、CBX6、CBX7、CBX8对哺乳动物个体发育调节及肿瘤发生过程的分子机制并没有系统的论述。本综述主要将这五种CBX蛋白在转录分子水平上的所发挥的功能进行相关的介绍,并且总结了CBX2、CBX4、CBX6、CBX7、CBX8各自最新的研究进展,体现出五种CBX蛋白的共同功能、各自独特的功能及彼此间的相互联系。
重要结论:总结了在哺乳动物中的五种CBX蛋白在胚胎发育和肿瘤形成等过程中独特的功能调节机制以及整体的相互作用,发现CBX作为PRC1的核心组分在基因表观遗传调控中发挥着极其重要的作用。
关键词组:
References:
Open peer comments: Debate/Discuss/Question/Opinion
<1>
DOI:
10.1631/jzus.B1400077
CLC number:
Q291; Q38
Download Full Text:
Downloaded:
3824
Download summary:
<Click Here>Downloaded:
2445Clicked:
16394
Cited:
8
On-line Access:
2024-08-27
Received:
2023-10-17
Revision Accepted:
2024-05-08
Crosschecked:
2014-04-16